Form 4: AnaptysBio Director Magda Marquet Reports Stock Transactions
SEC Form 4 Filing
Director Magda Marquet reports the acquisition and disposal of AnaptysBio common stock and restricted stock units on June 15, 2024.
Summary
- On June 15, 2024, Magda Marquet, a director of AnaptysBio, Inc. [ANAB], reported transactions involving the company's securities.
- Marquet acquired 3,900 shares of common stock at a price of $0.
- Simultaneously, Marquet disposed of 3,900 shares of common stock.
- These transactions involved the vesting and settlement of restricted stock units (RSUs).
- Following these transactions, Marquet directly owns 0 shares of AnaptysBio common stock.
- The RSUs vested 100% on the date of the Issuer's 2024 annual meeting of shareholders, subject to continued service.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company director, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders (directors, officers, and principal stockholders) to report transactions in their company's stock, providing transparency to the market.
Key Dates
| Date | Description |
|---|---|
| 06/15/2024 | Date of stock transactions (acquisition and disposal) and RSU vesting. |
| 06/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.